Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study

The objective of this study was to examine positive predictive value (PPV) of medication therapy management (MTM) eligibility criteria under Medicare Modernization Act (MMA) and Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial and ethnic groups. The study analyzed Medicare data (2012-2013) for 2 213 594 beneficiaries. Medication utilization issues were determined based on medication utilization measures mostly developed by Pharmacy Quality Alliance. MMA was associated with higher PPV than ACA in identifying individuals with medication utilization issues among non-Hispanic blacks (blacks) and Hispanics than non-Hispanic whites (whites). For example, odds ratio for having medication utilization issues to whites when examining MMA in 2013 and ACA were 1.09 (95% confidence interval [CI] = 1.04-1.15) among blacks, and 1.17 (95% CI = 1.10-1.24) among Hispanics, in the main analysis. Therefore, MMA was associated with 9% and 17% higher PPV than ACA in identifying patients with medication utilization issues among blacks and Hispanics, respectively, than whites.

[1]  Jill Emery,et al.  Introduction and literature review , 2013, The Tekenu and Ancient Egyptian Funerary Ritual.

[2]  K. Johnson,et al.  Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma , 2017, The Journal of asthma : official journal of the Association for the Care of Asthma.

[3]  S. Barlas.  CMS to Test Enhanced Medication Therapy Management Model: Aims for Greater Use of Pharmacists, Cost Savings, and Better Outcomes. , 2016, P & T : a peer-reviewed journal for formulary management.

[4]  Arturo Vargas-Bustamante,et al.  Racial and Ethnic Disparities in Health Care Access and Utilization Under the Affordable Care Act , 2016, Medical care.

[5]  M. Chisholm-Burns,et al.  Disparity implications of proposed 2015 Medicare eligibility criteria for medication therapy management services , 2015, Journal of pharmaceutical health services research: an official journal of the Royal Pharmaceutical Society of Great Britain.

[6]  Samantha P. Adams,et al.  Impact of Medicare Part D on Racial and Ethnic Minorities. , 2016, Diversity and equality in health and care.

[7]  K. Stockl,et al.  Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population , 2016, Journal of managed care & specialty pharmacy.

[8]  W. Cushman,et al.  Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups , 2015, Journal of managed care & specialty pharmacy.

[9]  B. Stuart,et al.  Should Eligibility for Medication Therapy Management Be Based on Drug Adherence? , 2014, Journal of managed care pharmacy : JMCP.

[10]  M. Chisholm-Burns,et al.  Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population. , 2014, Research in social & administrative pharmacy : RSAP.

[11]  W. Cushman,et al.  Effects of medicare part d on disparity implications of medication therapy management eligibility criteria. , 2014, American health & drug benefits.

[12]  Ya-Chen Tina Shih,et al.  Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria. , 2014, Journal of Pharmaceutical Health Services Research.

[13]  Ya-Chen Tina Shih,et al.  Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria. , 2013, Research in social & administrative pharmacy : RSAP.

[14]  Whitney R Johnson,et al.  Medicare program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs. Final rule. , 2014, Federal register.

[15]  Junling Wang,et al.  Historical trend of disparity implications of Medicare MTM eligibility criteria. , 2013, Research in social & administrative pharmacy : RSAP.

[16]  J. Wan,et al.  Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review , 2013, Expert review of pharmacoeconomics & outcomes research.

[17]  B. Pharm.,et al.  Disparity Implications of the Medicare MTM Eligibility Criteria : A Literature Review , 2013 .

[18]  S. Hong,et al.  Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population. , 2012, Journal of the American Pharmacists Association : JAPhA.

[19]  W. Doucette,et al.  Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention , 2011, Journal of clinical hypertension.

[20]  T. Shaffer,et al.  Residential and health care transition patterns among older medicare beneficiaries over time. , 2011, The Gerontologist.

[21]  W. Cushman,et al.  Disparity implications of Medicare eligibility criteria for medication therapy management services. , 2010, Health services research.

[22]  H. Koh.  A 2020 vision for healthy people. , 2010, New England Journal of Medicine.

[23]  R. Cipolle,et al.  Clinical and economic outcomes of medication therapy management services: the Minnesota experience. , 2008, Journal of the American Pharmacists Association : JAPhA.

[24]  K. Suda,et al.  A comparison of direct medical costs across racial and ethnic groups among children with cancer , 2008, Current medical research and opinion.

[25]  N. Miller,et al.  Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. , 2007, Health services research.

[26]  Charles E. Menifield,et al.  Disparities in health care: minority elders at risk. , 2007, The ABNF journal : official journal of the Association of Black Nursing Faculty in Higher Education, Inc.

[27]  S. White-Means,et al.  The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors* , 2007, Current medical research and opinion.

[28]  D. Malone,et al.  Characteristics of Older Adults Who Meet the Annual Prescription Drug Expenditure Threshold for Medicare Medication Therapy Management Programs , 2007, Journal of managed care pharmacy : JMCP.

[29]  N. Miller,et al.  Disparities in Access to Essential New Prescription Drugs between Non-Hispanic Whites, Non-Hispanic Blacks, and Hispanic Whites , 2006, Medical care research and review : MCRR.

[30]  J. Magaziner,et al.  Inappropriate Drug Use and Risk of Transition to Nursing Homes Among Community-Dwelling Older Adults , 2006, Medical care.

[31]  R. Coates,et al.  Decision making in prostate-specific antigen screening National Health Interview Survey, 2000. , 2006, American journal of preventive medicine.

[32]  Hhs Centers for Medicare Medicare Services.  Medicare program; Medicare prescription drug benefit. Final rule. , 2005, Federal register.

[33]  O. Carter-Pokras,et al.  Healthcare disparities and models for change. , 2004, The American journal of managed care.

[34]  B. Briesacher,et al.  Racial and Ethnic Disparities in Prescription Coverage and Medication Use , 2003, Health care financing review.

[35]  Usha Sambamoorthi,et al.  Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. , 2003, Preventive medicine.

[36]  J. Escarce,et al.  Racial and ethnic differences in public and private medical care expenditures among aged Medicare beneficiaries. , 2003, The Milbank quarterly.

[37]  Randall S. Brown,et al.  Racial Disparities in Prescription Drug Use Among Dually Eligible Beneficiaries , 2003, Health care financing review.

[38]  Adrienne Y. Stith,et al.  Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .

[39]  R. Andersen,et al.  The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. , 2000, Health services research.

[40]  M. Gornick.  Disparities in Medicare Services: Potential Causes, Plausible Explanations, and Recommendations , 2000, Health care financing review.

[41]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[42]  P Stein,et al.  The Consumer Price Index (CPI). , 1992, Trends & techniques in the contemporary dental laboratory.

[43]  ROBERT W. Johnson,et al.  Healthy people. , 1985, Canadian journal of public health = Revue canadienne de sante publique.